| abstract |
Disclosed is a prostatic disease evaluation method which can evaluate the condition of a prostatic disease with high accuracy by utilizing, among the blood concentrations of amino acids, the blood concentration of an amino acid involved in the condition of the prostatic disease. The prostatic disease evaluation method comprises the steps of: measuring an amino acid concentration data associated with the concentrations of amino acids in the blood collected from a subject to be evaluated; and evaluating the condition of the prostatic disease including at least one member selected from prostate cancer and prostatic hyperplasia in the subject based on the value of the concentration of at least one member selected from Tau, Thr, Ser, Asn, Glu, Pro, Gly, Ala, Cit, ABA, Val, Met, Ile, Leu, Phe, His, Trp, Orn, Lys and Cys2 included in the amino acid concentration data for the subject measured in the aforementioned step. |